We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance to support the health system to reduce inequalities in screening.
Training and continuing professional development for people working in the sickle cell and thalassaemia screening programme in England.
Information and resources for health professionals who provide counselling for people at risk of having a baby with sickle cell disease or thalassaemia.
This document sets out for the programme specific operating model (PSOM) for quality assurance of the NHS antenatal and newborn (ANNB) screening programmes.
Advice for people who commission, fund, deliver and evaluate health outreach programmes.
This document describes the sickle cell and thalassamia (SCT) screening pathways.
Information for pregnant women to understand what it means to be an alpha zero thalassaemia carrier.
Information to help healthcare professionals speak with parents at risk of having a child with thalassaemia.
Information for commissioners and screening providers, to help improve access to screening for people with severe mental illness.
This provides details for screening providers on moving from printed leaflets to digital alternatives.
Information to help healthcare professionals speak with parents at risk of having a child with sickle cell disease.
These leaflets, in English, French, Bengali and Urdu, can help healthcare professionals speak with people about beta thalassaemia major.
Information for pregnant women to understand what it means to be a delta beta thalassaemia.
Guidance on using the sickle cell and thalassaemia (SCT) newborn outcomes solution web system.
An overview of the sickle cell and thalassaemia (SCT) screening end-to-end pathway.
Statutory guidance to help health professionals provide an inclusive screening programme to all eligible people.
Instructions on how to submit key performance indicator (KPI) data for the antenatal and newborn blood spot (NBS) screening programmes.
Sickle cell and thalassaemia high/low prevalence laboratory return 2024 to 2025
Antenatal maternity services annual standards return 2024 to 2025
Executive summary of quality assurance (QA) visit to Taunton and Somerset NHS Foundation Trust antenatal and newborn screening programmes on 17 September 2019.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).